- Another shadow banking hit – but otherwise, Barclays looks fine The Guardian —
- Barclays Eyes Over 50% Recovery on MFS as Asset Hunt Uncertain Bloomberg —
- Barclays Reports £66 Billion Exposure to Non-Bank Lending Bloomberg —
- Barclays sets aside £823m for bad debts after fraud hit but profits rise The Argus —
- Barclays sets aside £823m for bad debts after fraud hit but profits rise LBC —
- Barclays sets aside £823m for bad debts after fraud hit but profits rise Belfast Telegraph —
- Barclays sets aside £823m for bad debts after fraud hit but profits rise The Standard —
- Barclays sets aside £823m for bad debts after fraud hit but profits rise The Independent —
- Barclays GAAP EPS of 14.10p, revenue of £8.16B; reaffirms all 2026 and 2028 targets, announces £500m buyback Seeking Alpha —
- Barclays GAAP EPS of 14.10p, revenue of £8.16B; reffirms all 2026 and 2028 targets, announces £500m buyback Seeking Alpha —
- Barclays Posts Higher Profit on Top-Line Growth Wall Street Journal —
- Barclays overcomes £200mn credit hit to boost profits Financial Times —
- Barclays reports flat first quarter profits RTE —
- Barclays cuts back risky lending after £228m hit from UK mortgage firm MFS The Guardian —
- Barclays takes £228m hit from collapse of specialist lender Daily Mail —
- Barclays reserves £823m for bad loans as investment bank seals record City AM —
Marfan syndrome
Genetic disorder of the connective tissue
Marfan syndrome (MFS) is a multi-systemic genetic disorder that affects the connective tissue. People with the condition are often tall and thin, with long arms, legs, fingers, and toes. They also typically have exceptionally flexible joints and abnormally curved spines. The most serious complications involve the heart and aorta, with an increased risk of mitral valve prolapse and aortic aneurysm. The lungs, eyes, bones, and the covering of the spinal cord are also commonly affected. The severity of the symptoms is variable.
Also known as...
Marfan's syndrome and MFS
Barclays profits beat estimates